Sebaceous Carcinoma Treatment Outcomes: A Multicenter Study

Sebaceous Carcinoma Treatment Outcomes Sebaceous carcinoma (SC) is a rare tumor found in the sebaceous glands. The sebaceous gland is the gland that lubricates our skin. Although it can develop anywhere on the body, sebaceous carcinomas are often found on eyelids. It’s responsible for 0.7% of all cutaneous malignancies. From 2000

5 Health Trends to Follow in 2022

Patient Education This article is tailored for patients. Refer your patients to this article for them to learn more about their condition. 5 Health Trends to Follow in 2022 With each passing year, we observe an increasing health awareness among people of all ages. While the prevalence of a health-conscious mindset is

Diffuse-Type Tenosynovial Giant Cell Tumors: Treatments and Progression

Diffuse-Type Tenosynovial Giant Cell Tumors: Treatments and Progression Tenosynovial giant cell tumors (TGCT) - An Introduction Tenosynovial giant cell tumors (TGCT) are rare, locally invasive lesions of synovial origin that involve joints, tendon sheaths, and bursae.  TGCT may be intra- or extra-articular and is classified by growth pattern and clinical presentation as

Lung Spindle Cell Carcinoma Responsive to Pembrolizumab: A Rare Case Report

Lung Spindle Cell Carcinoma Responsive to Pembrolizumab: A Rare Case Report Overview  A male patient, 52 years of age, underwent pneumonectomy of the left lung. He was previously diagnosed with primary spindle cell carcinoma (pT4aN1M0, stage III B) with programmed death-ligand 1 expression (tumor proportion score ≥95%) and without epidermal growth factor

Breast Tomosynthesis Simulator for Virtual Clinical Trials

Breast Tomosynthesis Simulator for Virtual Clinical Trials Summary  The use of computer models and simulation in predicting the clinical performance of x-ray imaging devices in silico and generating synthetic patient images for training and testing of machine learning algorithms is widely accepted today.  In this study, the researchers presented a detailed description of

Renal Cell Carcinoma- Prognosis via Albumin Levels

Renal Cell Carcinoma- Prognosis via Albumin Levels Metastatic renal cell carcinoma (mRCC) - An Introduction Renal cell carcinoma (RCC) constitutes approximately 90% of all urologic malignancies. Approximately 30% of patients with RCC present with metastatic disease, and amongst those with localized disease, a substantial proportion will recur. Before 2005, immunotherapy with interleukin-2

Diagnostic Error Causing Cases of Cytopenia

Diagnostic Error Causing Cases of Cytopenia Summary  Many psychotropic drugs are known to cause cytopenia after increasing dosage or during the beginning of treatment. Cytopenia can also be caused by other conditions such as leukemia. These two case reports report on cases of cytopenia which happened during adjustment of psychotropic mediations in